Respirology

Papers
(The H4-Index of Respirology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
P4‐13: Assessment of the impact of atmospheric air microsuspensions on the respiratory function of patients with chronic obstructive pulmonary disease130
O5‐5: Current smoking by socioeconomic status in a representative Japanese population115
P6‐17: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis (MTB) identification in patients with pulmonary tuberculosis96
P5‐109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID‐19 patient94
O18‐3: Analysis of nocturnal desaturation waveform by using algorithm in the patients with idiopathic pulmonary fibrosis86
P7‐65: Correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD)78
P8‐177: Chest wall Ewing's sarcoma – A diagnostic and therapeutic adventure76
P11‐14: Blood gas analysis and alveolar‐arterial gradient as predictor of mortality confirmed COVID‐19 patients outcome in Tertiary Referral Hospital61
P5‐43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID‐19 pneumonia in pregnancy50
P10‐12: Risk factors for poor sleep quality and excessive daytime sleepiness in late pregnancy: A preliminary analysis of a cross‐sectional survey49
P1‐15: Chest X‐ray improvement in COVID‐19 moderate symptoms with remdesvir and favipiravir: A comparative study46
P1‐66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report45
O5‐4: The effects of smoking cessation therapy on pulmonary function and predictive factor of the FEV1 increase45
P8‐26: Study of the number of courses required for the first response to immune checkpoint inhibitor (+chemo) therapy for lung cancer45
O20‐1: Spinal cord infarction after bronchial artery embolization using coils for hemoptysis: A single‐center retrospective analysis of 3046 procedures42
O18‐5: Sleep apnea and academic performance: A study on medical students using the Berlin questionnaire40
P16‐93: Preliminary analysis of serum risk factors during an acute exacerbation of chronic fibrosing interstitial pneumonia: A multi‐institutional prospective study40
O3‐6: The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements38
P6‐28: Clinical case of using intravenous forms of anti‐tuberculosis drugs to improve the treatment efficiency of tuberculosis in patients with malabsorption syndrome (MS)36
P12‐21: The recommended image features of peripheral lung parenchymal targets for diagnosis by CT‐guided needle biopsy36
P1‐88: Persistent bilateral unprovoked pulmonary embolism ‐ A case of chronic thromboembolic pulmonary hypertension in a young lady with seronegative antiphospholipid syndrome36
P6‐36: Components system of nitric oxide as markers of pulmonary multi‐drug resistant tuberculosis process activity36
P9‐27: Clinical feature and effectiveness of benralizumab therapy for severe asthma34
P8‐83: Giant pleuro parenchymal metastases from a rare primary tumor34
P9‐85: The reaction of the pituitary‐adrenal system to cold bronchoprovocation in asthma patients with subclinical hypothyroidism33
P11‐8: Surviving covid: A case report on the first covid survivor after extracorporeal membrane oxygenation (ECMO) in the Philippines33
33
P5‐55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?33
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients32
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma29
APSR 2024 Abstracts29
Bayesian adaptive clinical trial designs for respiratory medicine29
0.19856691360474